Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience

被引：0
|
作者：
Gowin, Krisstina L. [1 ]
Jain, Tania [1 ]
Kosiorek, Heidi E. [2 ]
Camoriano, John [1 ]
Tibes, Raoul [1 ]
Palmer, Jeanne [1 ]
Mesa, Ruben A. [1 ]
机构：
[1] Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Acute psychosis after injection of pegylated interferon alpha-2a
    Thome, J
    Knopf, U
    EUROPEAN PSYCHIATRY, 2003, 18 (03) : 142 - 143
  • [22] LOW-DOSE INTERFERON ALPHA-2A TREATMENT IN REFRACTORY BEHCET UVEITIS: A SINGLE CENTER EXPERIENCE
    Yilmaz, S. G.
    Keser, G.
    Yilmaz, Z.
    Aksu, K.
    Ates, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 927 - 927
  • [23] Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting
    Gill, Harinder
    Leung, Garret M. K.
    Yim, Rita
    Lee, Paul
    Pang, Herbert H.
    Ip, Ho-Wan
    Leung, Rock Y. Y.
    Li, Jun
    Panagiotou, Gianni
    Ma, Edmond S. K.
    Kwong, Yok-Lam
    HEMATOLOGY, 2020, 25 (01) : 247 - 257
  • [24] Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
    Tremblay, Douglas
    Vogel, Alexander S.
    Moshier, Erin
    Hoffman, Ronald
    Kremyanskaya, Marina
    Zhou, Selena
    Schiano, Thomas
    Mascarenhas, John
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (01) : 72 - 73
  • [25] Pegylated interferon alpha-2a treatment in HCV positive patients after liver transplantation
    Neumann, U. P.
    Bahra, M.
    Berg, T.
    Scmeding, M.
    Langrehr, J. M.
    Neuhaus, P.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S55 - S55
  • [26] Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience
    Paschos, Paschalis
    Vlachaki, Efthimia
    Pasvanti, Chrisoula
    Sinakos, Emmanouil
    Kalpaka, Anastasia
    Klonizakis, Philippos
    Perifanis, Vasilios
    ACTA HAEMATOLOGICA, 2011, 126 (04) : 231 - 233
  • [27] Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms
    Bahcecioglu, Adile Begum
    Etgul, Sezgin
    Aslan, Tuncay
    Aydin, Muruvvet Seda
    Malkan, Umit Yavuz
    Okay, Mufide
    Ozdemir, Evren
    Ciftciler, Rafiye
    Goker, Hakan
    Buyukasik, Yahya
    BLOOD, 2016, 128 (22)
  • [28] Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C
    Kose, Sukran
    Senger, Suheyla Serin
    Ersan, Gursel
    Cavdar, Gulsun
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 115 - 119
  • [29] COST-EFFECTIVENESS ANALYSIS OF PEGYLATED INTERFERON ALPHA-2A VERSUS PEGYLATED INTERFERON ALPHA-2B IN THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN POLAND
    Macioch, T.
    Paweska, J.
    Niewada, M.
    Berak, H.
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    VALUE IN HEALTH, 2011, 14 (07) : A274 - A275
  • [30] The Retreatment of Genotype 4 Chronic Hepatitis C Patients with Pegylated Interferon Alpha-2a and Ribavirin
    Peedikayil, Musthafa
    Al Ashgar, Hamad
    Al Kahtani, Khalid
    Al Sohaibani, Fahad
    Ingvar, Kagevi
    Al Quaiz, Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S134 - S134
12345